Progetto Q-NRG INT-P Cofinanziato dall'Unione Europea - www.europa.eu Avviso Pubblico “Voucher Internazionalizzazione” di cui alla Det. n. G10195 del 26/07/2019 - POR FESR LAZIO 2014-2020 – CUP F14E20000090007 – Domanda prot. n. A0331-2019-31351 Progetto approvato con Determinazione n. G02590 del 06/03/2020 pubblicata sul BURL n. 23 del 10/03/2020   Titolo del progetto: “Q-NRG International...

COSMED headquartered in Rome, Italy, leading manufacturer of Metabolic and Body composition technologies, has acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for Hemodynamic (Cardiac Output), Ventilation Heterogeneity (Lung Clearance Index) and Metabolic measurements (VO2Max). Innovision’s products are a perfect match to COSMED’s...

The FDA has granted marketing approval for the device in the US market where we expect to launch the product during the next ASPEN 2020 Nutrition conference taking place in Tampa, FL on March 28-31. Q-NRG is a result of COSMED’s collaboration with world-class institutes in the field of nutrition support in intensive care units. Product concept and specifications have been designed together with...

During these exceptional times, we would like to inform you that COSMED is adapting to the COVID-19 situation with diligence and is trying to face this big challenge with determination.We wanted to take a moment to share with our customers, partners and communities how COSMED is responding to this evolving situation. Supporting our people and communitiesCOSMED has always been committed to its employees...